SCHEMBL21099073

SCHEMBL21099073

c1ccc(-c2cc(-c3cccc(-c4ccc(-c5cc(-c6ccccn6)cc(-c6ccccn6)c5)c5ccccc45)c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
DHODH Q02127 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
LMNA P02545 3/20 0.44
GLA P06280 1/20 0.44
NTSR1 P30989 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
METAP1 P53582 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
MAOB P27338 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21099075 0.96 MAPK1 (0.49) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL19009466 0.93 TSHR (0.49) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL18679989 0.92 MAPK1 (0.46) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL21099079 0.92 HSD17B10 (0.48) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL20195347 0.92 KDM4E (0.44) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL21098923 0.89 HSD17B10 (0.42) MAPK1TSHRHSD17B10DHODHKDM4E
SCHEMBL18680021 0.88 MAPK1 (0.47) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL18680016 0.88 MAPK1 (0.47) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL21099054 0.87 MAPK1 (0.43) MAPK1TSHRHSD17B10DHODHMEN1
SCHEMBL21099056 0.87 KDM4E (0.46) MAPK1TSHRHSD17B10DHODHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323006-B2 Heterocyclic compound and organic light emitting element using same LG CHEM, LTD. (KR) 2019-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323006-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, NR2E3 MAPK1 3653/4885TSHR 3517/4885HSD17B10 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.